Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sanofi India Gains 5%; BSE HEALTHCARE Index Up 0.1%
Wed, 19 Jun 9:59

Sanofi India share price has zoomed 5% and is presently trading at Rs 7,539.6.

Meanwhile, the BSE HEALTHCARE index is at 37,154.6 (up 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are Biocon (up 2.8%) and Torrent Pharma (up 2.8%).

GLAND PHARMA (down 1.3%) and SUN PHARMA ADV. RES. (down 1.2%) are among the top losers today.

Over the last one year, Sanofi India has moved up from Rs 6,892.0 to Rs 7,539.6, registering a gain of Rs 647.6 (up 9.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 24,514.7 to 37,154.6, registering a gain of 51.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 102.9%), Jubilant Pharmova (up 97.3%) and POLY MEDICURE (up 96.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 77,415.2 (up 0.1%).

The top gainers among the BSE Sensex today are Indusind Bank (up 2.3%) and ICICI Bank (up 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and ICICI Bank.

In the meantime, NSE Nifty is at 23,588.6 (up 0.1%). Indusind Bank and ICICI Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,228.5 to 77,415.2, registering a gain of 14,186.7 points (up 22.4%).

Sanofi India Financial Update...

Sanofi India net profit fell 28.3% YoY to Rs 1,366 million for the quarter ended March 2024, compared to a profit of Rs 1,904 million a year ago. Net sales declined 0.6% to Rs 7,324 million during the period as against Rs 7,365 million in January-March 2023.

For the year ended December 2023, Sanofi India reported 2.9% decrease in net profit to Rs 6,029 million compared to net profit of Rs 6,206 million during FY22. Revenue of the company grew 2.9% to Rs 28,511 million during FY23.

The current Price to earnings ratio of Sanofi India, based on rolling 12 month earnings, stands at 31.6.


Equitymaster requests your view! Post a comment on "Sanofi India Gains 5%; BSE HEALTHCARE Index Up 0.1%". Click here!